KLOW

What is KLOW

KLOW is a research-grade blend of four peptides that have each been studied for tissue repair and inflammation control. The four components are BPC-157, TB-500, GHK-Cu and KPV. Instead of mixing them in the lab, the peptides are co-lyophilized in a single vial and reconstituted together. This is how the blend is used in published combination protocols and how most peptide labs supply it.

The name "KLOW" comes from extending the well-known GLOW blend (GHK-Cu + BPC-157 + TB-500) with KPV, the C-terminal anti-inflammatory tripeptide of alpha-MSH. It is a popular "research stack" because each peptide hits a different part of the repair process: structural rebuilding, cell migration, collagen synthesis and inflammation damping.

How it works

Each component plays a different role in tissue and skin research models.

BPC-157 is a stable pentadecapeptide originally found in human gastric juice. In animal studies it activates the VEGFR2 receptor and the Akt-eNOS pathway, which together drive new blood vessel formation and support tendon, muscle and gut healing. It is the most studied "body protection compound" in the regenerative peptide space.

TB-500 is the active fragment of thymosin beta-4, the main G-actin-binding peptide in the body. By regulating the actin pool, it helps fibroblasts and stem cells migrate to the injury site. Studies in rats, mice and pigs show faster dermal wound closure, better corneal repair and reduced post-injury inflammation.

GHK-Cu is a small copper-binding tripeptide first identified in human plasma. It triggers collagen production in skin fibroblasts, supports capillary formation and modulates thousands of genes linked to repair and renewal in cell-culture work.

KPV is the C-terminal tripeptide of alpha-MSH. It blocks the NF-kB pathway and is the most researched of the alpha-MSH-derived anti-inflammatory peptides. In gut models it is taken up through the PepT1 transporter and reduces colitis severity.

The rationale for stacking them is straightforward: BPC-157 and TB-500 are paired in the regenerative literature for systemic and structural healing, while GHK-Cu and KPV are paired in the skin and anti-inflammation literature. Putting all four in one vial covers both axes in a single protocol.

Often studied alongside

Researchers comparing single-peptide and blend effects usually keep the individual components on hand. We supply each of the four KLOW peptides on its own.

A three-peptide variant, "GLOW", is also common in skin-focused protocols. It drops the KPV component and supplies GHK-Cu, BPC-157 and TB-500.

For reconstitution, the standard solvent in published protocols is bacteriostatic or sterile water. Once dissolved, the solution takes on a faint blue tint from the GHK copper complex.

Documentation